(Q36107175)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853588%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

review article

1 reference

title

Treatment of malignant gliomas: radiotherapy, chemotherapy and integration of new targeted agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853588%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853588%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

4

Nicolaus Andratschke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853588%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Carsten Nieder

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853588%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Anca L Grosu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853588%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Michael Molls

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853588%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

language of work or name

1 reference

1 July 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853588%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853588%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853588%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853588%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

691-703

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853588%20AND%20SRC:MED&resulttype=core&format=json

Loss of heterozygosity for loci on chromosome arms 1p and 10q in oligodendroglial tumors: relationship to outcome and chemosensitivity

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Correlation between genetic alteration and long‐term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

The challenge of p53 as prognostic and predictive factor in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Identification of molecular subtypes of glioblastoma by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Proton magnetic resonance spectroscopic imaging can predict length of survival in patients with supratentorial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Epidermal growth factor receptor: an independent predictor of survival in astrocytic tumors given definitive irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Role of resection for newly diagnosed malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Protracted exposure radiosensitization of experimental human malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

A phase II study of preradiation chemotherapy followed by external beam radiotherapy for the treatment of patients with newly diagnosed glioblastoma multiforme: an Eastern Cooperative Oncology Group study (E2393).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Immunohistochemical expression of P-glycoprotein and glutathione S-transferases in cerebral gliomas and response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

The significance of the expression of tumor suppressor gene DCC in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Phase II trial of gefitinib in recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

The role of transforming growth factor beta in glioma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Adoptive immunotherapy for malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

Telomerase as a therapeutic target for malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.4.691

21 January 2018

Identifiers

DOI

10.1586/14737175.4.4.691

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853588%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference